RxDoctor Payments Data

Vikram Chatrath, MD

Orthopaedic Surgery · Bossier City, LANPI 1205264074

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (53.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Zimmer Biomet at 39.6% of the total. Reporting peaked in 2022 at $3,241 and has fallen 95.2% since, to $156 in 2025.

$9,369in general payments, 2019–2025

Across 97 payments — averaging $96.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$4K
  • Midsouth Orthopedics Inc.$1K
  • Medtronic$1K
  • Maxx Orthopedics, Inc.$1K
  • Stryker$894
  • Gemini Medical LLC$667
  • plus $703 from 13 others

What the payments were for

  • Consulting fees$491%
  • Travel & lodging$4,99553%
  • Food & beverage$2,45826%
  • Education$1,86720%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,369 in reported general payments places this provider in the 70th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana →

Medicare billing

Part B allowed, 2024
$271,028
Medicare patients
417
Services billed
12,041

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam176$662
Diclofenac Sodium33$301
Celecoxib22$221
Gabapentin24$187
Methylprednisolone16$99

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bossier City

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →